Welcome to the 29th Annual Canadian Radiation Oncology Refresher Course in 2024, hosted by McGill University!
Join us virtually from January 21 to 26 for an unparalleled experience curated by our esteemed speakers. These accomplished individuals, experts in their respective fields, will guide you through the latest developments and best practices, ensuring a week of enriching insights and professional growth.
Our carefully selected faculty brings a wealth of knowledge and experience, promising engaging presentations, interactive discussions, and ample networking opportunities. As we navigate the virtual landscape, their commitment to academic excellence will be evident, providing you with a unique platform to stay ahead in your industry.
Immerse yourself in a dynamic week of learning and collaboration, where McGill University and our distinguished speakers converge to create a stimulating environment. Whether you’re a seasoned professional or just starting your journey, the 29th Annual Canadian Radiation Oncology Refresher Course promises to be a gateway to innovation and advancement.
Welcome to a week of inspiration and excellence!
James Tsui, MDCM, PhD, FRCPC
Dr. James Tsui is a Radiation Oncologist in the Department of Oncology at McGill Health University Center and an Assistant Professor in the Gerald Bronfman Department of Oncology at McGill University.
Dr. James Tsui graduated with distinction in 2006 with a Bachelor in Electrical Engineering Co-operative Program from Concordia University. Dr. Tsui then pursued research in computational neuroscience and visual neurophysiology, and obtained a Ph.D. in Neuroscience at McGill University in 2013. Dr. James Tsui completed his medical school in 2015 and residency training in Radiation Oncology in 2020, both also at McGill University.
Dr. James Tsui completed his fellowship in brachytherapy at the Dana Farber/ Brigham and Women’s Cancer Center at Harvard University 2021, and a Professional Master’s in Artificial Intelligence (AI) with a focus in Deep Learning at MILA / University of Montreal 2023. He has an interest in the intersection between AI and clinical practice.
Jordan Stosky, MD, FRCPC
Dr. Jordan Stosky is a Radiation Oncologist treating patients with skin cancers, breast cancers, and sarcomas.
Dr. Stosky is the Program Director of the University of Calgary Radiation Oncology Residency Program, and holds a post graduate fellowship in sarcoma radiotherapy, and MRI simulation.
Carolyn Freeman, MB BS, FRCPC
Dr. Carolyn Freeman is a Radiation Oncologist practising at the Cedars Cancer Centre of the McGill University Health Centre (MUHC). She is a Professor of Oncology and Pediatrics at McGill University and holder of the Mike Rosenbloom Chair of Radiation Oncology.
Dr. Freeman was Director of Radiation Oncology at the MUHC and at McGill University from 1979 to 2011 and has served in leadership roles at all levels, including Chair of the Comité de radio-oncologie of the Direction de la lutte contre le cancer (provincial), Founding Member of the Canadian Association of Radiation Oncologists and Chair of the Radiotherapy Quality Assurance Committee of the National Cancer Institute of Canada (national), and Co-Chair of the Brain Tumour Strategy Committee of the Children’s Oncology Group and Founding Member and President of the Pediatric Radiation Oncology Society (international). In 2022, Dr. Freeman was appointed to the Order of Canada in recognition of her impactful career. Dr. Freeman’s clinical focus and research interests include pediatric oncology, soft tissue sarcomas, and health care quality improvement.
Anne-Marie Charpentier, MD FRCPC
A graduate of the Université de Montréal since 2006, Dr. Anne-Marie Charpentier completed her residency in radiation oncology in 2011 at the UdeM and her postdoctoral clinical studies at the Princess Margaret Cancer Centre in Toronto. In 2013, Dr. Charpentier completed an observation elective at the University of Pennsylvania Health System in Philadelphia. Her journey has allowed her to become an associate member of the Department of Hemato-Oncology at CHU Sainte-Justine, and Program Director of the Radiation Oncology residency program from 2018-2023.
Dr. Charpentier is a Radiation Oncologist with the CHUM / CHU Sainte-Justine Department of Radiation Oncology and an active participant in the CHUM’s academic mission as Assistant Clinical Professor in the Department of Radiology, Radiation Oncology and Nuclear Medicine at the University of Montreal.
Alexis Bujold, MD FRCPC
Dr. Alexis Bujold has graduated in Medicine from University of Montreal in 2003. Dr. Bujold did his residency in Radiation Oncology at University of Montreal, FRCPC in 2008 in Radiation Oncology and his fellowship in head and neck, lung and gastrointestinal cancers at Princess Margaret hospital in 2011.
Dr. Alexis Bujold is currently Associate clinic professor in the Department of Radiology, Radiation Oncology and Nuclear Medicine of the University of Montreal.
Dr. Bujold is also a staff member in the Service of Radiation Oncology, Department of Specialized Medicine, CIUSSS Est-Île-de-Montréal, Installation Maisonneuve-Rosemont.
Neil Kopek, MD, FRCPC
Dr. Neil Kopek is a Radiation Oncologist practising at the Cedars Cancer Centre of the McGill University Health Centre (MUHC) and an Assistant Professor in the Department of Oncology at McGill University. Dr. Kopek is the Radiation Oncology Fellowship Director at McGill University.
Dr. Kopek’s clinical focus is on stereotactic radiotherapy, lower gastrointestinal malignancies, lung, breast, hepatobiliary, and pancreatic cancers. Dr. Kopek’s research interests include rectal and lung cancer.
Dr. Scott Owen, MD
Dr. Scott Owen joined the MUHC in 2011 and practices oncology at the Cedar’s Cancer Center and the Montreal Neurological Institute. His primary clinical interests are in the treatment of lung malignancies and brain malignancies in adults. Dr. Owen is an Assistant Professor in McGill’s Department of Oncology, and former Program Director for McGill’s Medical Oncology Residency Training Program (2013-2019).
Prior to his appointment at the MUHC, Dr. Scott Owen completed his training in Internal Medicine and Medical Oncology at McGill University before pursuing a clinical fellowship in Pulmonary Oncology at Princess Margaret Hospital in Toronto, and a three-month Observership program in Neuro-Oncology at the Massachusett’s General Hospital in Boston.
Tarek Hijal, MDCM, MSc, FRCPC
Dr. Tarek Hijal is a Radiation Oncologist practising at the Cedars Cancer Centre of the McGill University Health Centre (MUHC), an Associate Professor in the Department of Oncology at McGill University and the Director of the Division of Radiation Oncology at the MUHC.
Dr. Tarek Hijal is an Associate Investigator at the MUHC’s Research Institute, where he co-leads the Health Informatics Group that created the Opal app, and focuses his research on the hypofractionated deliverapy of radiation in breast cancer. Most recently, Dr. Tarek Hijal was appointed as Chair of the Comité national de radio-oncologie of the Ministère de la santé et des services sociaux du Québec. His clinical focus is on breast, hematologic, and gastrointestinal radiation oncology.
Magali Lecavalier-Barsoum, MD FRCPC
Assistant Professor, Oncology, McGill University
Associate Member, McGill Centre for Translational Research in Cancer
Co-program director for the McGill Radiation Oncology residency program
Radiation Oncologist, Sir Mortimer B. Davis-Jewish Hospital
Dr. Magali Lecavalier-Barsoum did her fellowship and Masters in Toronto. Dr. Lecavalier-Barsoum works at the JGH since 2017, where she is the site-lead in thoracic malignancies.
William Parker, MSc., FCCPM
Mr. William Parker, the newly appointed Manager of Radio oncology Medical Physics at the MUHC Cedars Cancer Centre, boasts a distinguished career grounded in Medical Physics. Graduating with a Baccalaureate / Specialization in Physics from Concordia University and earning a Master’s Degree in Medical Radiation Physics from McGill University, Mr. William Parker embarked on his journey in 1995 as a clinical medical physicist and radiation safety officer in Gatineau. He then transferred to the MUHC in 1996.
With 28 years of experience, Mr. William Parker has been a key contributor to the field of Medical Physics, actively participating in local and national committees and serving as an Assistant Professor at McGill University. His profound understanding of physics principles is not only reflected in his academic roles but also in his hands-on involvement in clinical research, securing project funding, and publishing scientific work.
His multifaceted contributions encompass various capacities, including course coordination and instruction at McGill University, years of experience as a student supervisor, and an expert reviewer. Mr. William Parker’s exemplary career is underscored by numerous honors and awards, reflective of his dedication and impact in the field.
Horacio Patrocinio, MSc., FCCPM, FCOMP, DABR
For the last 30 years, Mr. Horacio Patrocinio has provided clinical medical physics service in the hospital environment. Mr. Horacio has been a teacher at the MSc, CEGEP and residency levels. He is the clinical coordinator of the McGill Radiation Oncology Physics residency program.
Mr. Horacio Patrocinio has held various positions on the board(s) of the COMP, CCPM, AQPMC and IMPCB and has carried out several expert missions on behalf of the IAEA in South America and Europe. Mr. Horacio Patrocinio has also consulted on a range of topics within the medical physics and radiation oncology. His interests include research in and clinical applications of stereotactic radiosurgery and radiotherapy, image-guided radiation therapy and brachytherapy.
Adam Mutsaers, MD FRCPC
Dr. Adam Mutsaers is a staff radiation oncologist at the London regional cancer program. Dr. Mutsaers completed his medical studies at McMaster university, residency at the London regional cancer program, and a fellowship at Sunnybrook in head and neck and thoracic malignancies. Dr. Adam Mutsaers treats head and neck, thoracic and skin malignancies.
Sonia Skamene, MDCM, MSc, FRCPC
Dr. Sonia Skamene is a Radiation Oncologist practising at the Cedars Cancer Centre of the McGill University Health Centre (MUHC) and is an Assistant Professor in the Gerald Bronfman Department of Oncology at McGill University.
Dr. Skamene is the Assistant Director of the Division of Radiation Oncology at the MUHC. She completed medical school at McGill University, her master’s degree at Queen’s University in Healthcare Quality, and fellowship in Supportive and Palliative Radiotherapy at Dana-Farber/Brigham and Women’s Cancer Center in Boston, MA. Her clinical focus is on pediatric, hematologic and palliative radiation oncology.
Dr. Skamene’s research interests include palliative radiotherapy, quality improvement in health care and serious illness communication. She serves as chair of the Radiation Oncology Quality Improvement Committee, co-chair of the Cancer Care Mission Capacity Building Subcommittee, and lead of the oncolology trainee Quality Improvement Curriculum. Dr. Skamene is also course director for McGill University’s ONCO 625 graduate course Quality Improvement: Principles and Methods.
Joanne Alfieri, MDCM, FRCPC, MMEd
Dr. Joanne Alfieri is a Radiation Oncologist practicing at the Cedars Cancer Centre of the McGill University Health Centre (MUHC) and is an Associate Professor in the Gerald Bronfman Department of Oncology at McGill University.
Dr. Joanne Alfieri is the Co-director of the Fellowship Training Program in Radiation Oncology and the Associate Chair for education of the Department of Oncology at McGill University. Dr. Alfieri is also Assistant Dean, Curricula for PGME at McGill. Her clinical focus is in gynecological and gastrointestinal cancers. Dr. Alfieri is an Associate Investigator at the MUHC’s Research Institute where she co-leads the Program for Women’s Cancer Research (Team PWR). Dr. Alfieri’s research interests include gynaecological malignancies and health sciences education.
Israël Fortin, MD FRCPC, MSc
Dr. Israël Fortin is an Université de Montréal radiation oncologist faculty member working at the Maisonneuve-Rosemont Hospital. He is specialized in Gynecological, Breast, Neurological and hematological cancer as well as in brachytherapy. Prior to joining the Maisonneuve-Rosemont Hospital, Dr. Fortin was a radiation oncologist at the CHUM, Montréal.
Dr. Fortin has completed a molecular and cellular cancer biology master’s degree in Quebec City prior to completing his medical school at Université de Montréal. He has then completed a Fellowship program in Gynecological cancer and brachytherapy in Vienna, Austria, where he has joined the EMBRACE group, has participated actively in EMBRACE research and were involved as a co-searcher in the elaboration of the EMBRACE II protocol. For his research, Dr. Fortin was awarded the Judith Stitt Award, for best abstract at the World Brachytherapy Congress in San Francisco in 2016. Dr. Fortin has also completed a master’s degree in public health and is a leader in the patient partnership in oncology. He served as Course Director for the 23rd Annual Canadian Exam preparation and Review Course for clinical and Radiation oncology in Montréal in 2018 and he is still involved in residents’ education.
Dr. Fortin Israël is director of the Continuous Education development of his department at Université de Montréal and is the east director of Canadian brachytherapy group. He is still active in brachytherapy on a national and international level.
Dr. Salman Faruqi, MD RCPSC
Dr. Salman Faruqi completed his Radiation Oncology residency at the University of Toronto and gained CNS expertise through an SRS/Spine SBRT fellowship at Sunnybrook Health Sciences Centre.
Currently practicing at the University of Calgary, Dr. Faruqi focuses on clinical activities related to the Central Nervous System (CNS) and Cutaneous sites, with a primary research interest in the treatment of brain metastases.
Dr. Salman Faruqi is the Alberta CNS provincial chair and Calgary cutaneous oncology site lead. Outside of his professional commitments, Salman is a devoted parent to two daughters under 5 who bring joy and mischief to his life.
Dr. Mark Corkum, MD RCPSC
Dr. Mark Corkum is a radiation oncologist at The Ottawa Hospital and Assistant Professor at the University of Ottawa. He specializes in the treatment of genitourinary cancers. He completed his medical school at Dalhousie University in Halifax, Nova Scotia and his residency training at Western University in London, Ontario.
Following this, Dr. Mark Corkum completed a fellowship in prostate brachytherapy at Sunnybrook Hospital and the University of Toronto, including obtaining an area of focused competence diploma in brachytherapy issued by the Royal College of Physicians and Surgeons of Canada. Dr. Mark Corkum also has a Master’s degree in Epidemiology from Dalhousie University. He has been a part of The Ottawa Hospital since 2021.
Dr. Kevin Martell, MD RCPSC
Dr. Kevin Martell is a Radiation Oncologist and renound Canadian brachytherapist. He obtained a Bachelor of Science with Honors in Physics and a Medical Doctorate at the University of Alberta. Dr. Martell completed residency in radiation oncology within the Department of Oncology, Cumming School of Medicine at the University of Calgary. Dr. Kevin Martell completed a brachytherapy fellowship in the Sunnybrook Health Sciences Centre at the University of Toronto, Toronto, Ontario specializing in genitourinary and gynecologic malignancies and was one of the first two radiation oncologists in Canada to receive an area of focused competence diploma from the Royal College of Physicians and Surgeons of Canada for brachytherapy training.
Dr. Kevin Martell has had a distinguished academic career and has received several awards, including being offered a prestigious Alberta Ingenuity grant and receiving national and international recognition for his work in brachytherapy. His primary clinical focus has been the treatment of genitourinary and gynecologic malignancies using advanced radiotherapy techniques. His research focus has been on integrating advanced imaging into brachytherapy treatments, use of artificial intelligence in optimizing brachytherapy treatments and the modelling of dosimetric and clinical outcomes from radiotherapy treatments in both genitourinary and gynecologic cancers.
Dr. Khalil Sultanem, MD FRCP
Dr. Khalil Sultanem is the Division Chief of the Segal Cancer Center’s Radiation Oncology facility at the Sir Mortimer B. Davis Jewish General Hospital.
Dr. Sultanem completed his Doctor of Medicine at Université de Sherbrooke and his residency in Radiation Oncology at McGill University. Dr. Khalil Sultanem also completed a fellowship in Head and Neck Oncology at the University of California, San Francisco.
Dr. Khalil Sultanem has also held the position of Director of l’Assocation des Radio-oncologues du Québec. Residency program director and Colead of the Rossy Cancer Network.
Dr. Sultanem is an Assistant Professor at McGill University and his numerous publications can be found in leading scientific journals.